Related Experiment Video
Updated: Aug 2, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Schizophrenia and co-morbidity risk: Evidence from a data driven phenomewide association study
Anwar Mulugeta1, Vijayaprakash Suppiah2, Elina Hyppönen3
1Australian Centre for Precision Health, University of South Australia, Adelaide, Australia; Department of Pharmacology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Genetic risk for schizophrenia is linked to increased odds of anxiety, bipolar disorder, and depression. This study also found associations with lower vitamin D and other biomarkers, suggesting broader health management for patients.
Area of Science:
- Psychiatric Genetics
- Complex Disease Epidemiology
- Biomarker Discovery
Background:
- Schizophrenia is a severe psychiatric disorder with high morbidity and mortality.
- Understanding its genetic underpinnings and associated health risks is crucial for patient care.
Purpose of the Study:
- To investigate the phenotypic associations of schizophrenia using a genetic risk score (GRS).
- To identify causal relationships between schizophrenia and various disease outcomes.
- To explore the association of schizophrenia with serum, urine, and neuroimaging biomarkers.
Main Methods:
- Utilized UK Biobank data from 337,484 participants.
- Performed Phenome-Wide Association Studies (PheWAS) with a schizophrenia GRS against 1135 disease outcomes.
- Employed Mendelian Randomization (MR) to assess causality and analyzed biomarker data.
Main Results:
- Schizophrenia GRS associated with 54 disease outcomes, including higher odds for anxiety, bipolar disorder, major depressive disorder, and suicidal ideation.
- Causal links found with 10 distinct diseases; inverse associations observed for type 1 diabetes, coronary atherosclerosis, and musculoskeletal disorders.
- Associated with lower serum 25(OH)D, gamma glutamyltransferase, cystatin C, and serum creatinine; no association with neuroimaging markers.
Conclusions:
- Confirms comorbidity of schizophrenia with other mental health disorders.
- Biomarker associations suggest potential influence of lifestyle factors.
- Highlights the need for comprehensive health screening and management in schizophrenia patients.
More Related Videos
Related Concept Videos
Psychological and Sociocultural Causes of Schizophrenia
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Schizophrenia
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Psychosis and Antipsychotic Drugs: Overview

